iBio Inc.

IBIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

+$0.07 (+5.56%)

At close: Sep 22, 2026, 4:00 PM ET

$1.36

+$0.03 (+2.23%)

After-hours: Sep 22, 2026, 7:49 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.56%

(1D)

Rating

Updated: Sep 8, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $21M

1D Range

1.24 1.37

52W Range

0.77 3.82

Valuation (TTM)

PE -3.82

PB 0.23

EV/EBITDA 2.04

Valuation (NTM)

Forward PE N/A

Forward PEG -0.07

Price Target $5

Cash Flow

FCF Yield -119.6%

SBC Adj. FCF Yield -126.5%

SBC Impact -5.8%

Margins

Gross Margin 100.0%

Operating Margin -35141.0%

FCF Margin -23796.0%

Growth (CAGR)

Revenue 3Y | 5Y -25.9% | -46.9%

Dil EPS 3Y | 5Y 122.4% | 93.5%

FCF 3Y | 5Y -13.0% | 25.1%

Returns

ROA -33.3%

ROE -47.9%

ROIC -40.0%

Financial Health

Net Cash

$87.49M

Current Ratio 7.85

Interest Coverage -663.04

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two ...

Sector Healthcare

Industry Biotechnology

Employees 20

IPO Date Aug 18, 2008

Website www.ibioinc.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+275.94%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞